Wavemaker 360

Wavemaker 360 is an early-stage investment firm that specializes in supporting healthcare start-ups in securing seed and series A funding. Established in 2018 through a partnership between Wavemaker, a venture capital firm focused on technology startups, and Three-Sixty Advisory, a healthcare consultancy and business accelerator, Wavemaker 360 is based in Pasadena, California. The firm primarily seeks investment opportunities in companies located in Southern California, with plans to expand its reach to other regions across the United States and internationally.

Jay Goss

General Partner

Kwame Ulmer

Venture Partner

80 past transactions

RubyWell

Seed Round in 2025
RubyWell is an intelligent and automated guide that helps family caregivers regain financial stability by continuously discovering and delivering new savings, benefits, and compensation opportunities.

AstroMind

Seed Round in 2024
AstroMind is a technology company.

Citizen Health

Seed Round in 2024
Over 350+ million people worldwide are affected by one of the 10,000+ rare diseases of which 95% do not have a single treatment available. Through our AI-powered platform, we liberate and structure data to radically improve rare and complex disease treatment, widen access to expert care, and revolutionize the development of new medicines at a fraction of the speed previously proven possible. Patients can share their health data across our multi-sided platform with caregivers, providers and researchers to illuminate better treatment and support options, while bringing therapies to patients faster. We support thousands of patients, work with a rapidly growing network of patient advocacy organizations, and innovate with leading biopharma organizations to accelerate therapies, always ensuring patients remain at the center.

AstroMind

Seed Round in 2024
AstroMind is a technology company.

Esperto Medical

Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostic tools for both hospital and remote patient monitoring. The company utilizes a proprietary technology called resonance sonomanometry, which employs acoustic stimulation to measure blood pressure continuously and noninvasively, eliminating the need for calibration. By offering round-the-clock monitoring capabilities, Esperto Medical aims to enhance patient care and accessibility, allowing individuals to track their vital signs conveniently from home or within clinical settings.

FreeNav

Seed Round in 2024
FreeNav, established in 2021, specializes in developing wireless electromagnetic (EM) tracking solutions for medical instruments used in minimally invasive procedures. Based in the Twin Cities of Minneapolis-St. Paul, the company equips instrument manufacturers with advanced technology to create trackable tools, enhancing clinical users' visualization and navigation capabilities. FreeNav's modular, accurate, and reliable systems aim to improve the precision and efficiency of medical procedures by overcoming existing tracking limitations.

Feeling Great

Seed Round in 2024
Feeling Great is a digital health company that specializes in mental health support. It offers an app featuring an AI-powered chatbot, interactive courses, self-help exercises, and evidence-based treatment information. The platform aims to help individuals manage depression and anxiety, build coping mechanisms, and enhance overall well-being.

Selfii

Seed Round in 2024
Selfii is a healthcare technology company that operates a data collection platform. It aggregates and structures patient-consented healthcare data from various sources like electronic health records and patient-generated data. This data is then transformed into a comprehensive medical knowledge graph, enabling researchers and healthcare professionals to accelerate clinical research, AI development, and app creation.

Marigold Health

Series A in 2024
Marigold Health operates a social network community platform designed to provide text-based group therapies for individuals facing mental health and substance use challenges. The platform facilitates anonymous support groups, allowing patients to engage with one another and receive guidance from coaches who have personal recovery experiences. By leveraging AI-augmented chat support, Marigold Health enhances the capacity of care teams while ensuring that patients receive personalized, stigma-free assistance. The company collaborates directly with treatment providers and managed care organizations within the Medicaid market to improve access to on-demand group therapies and foster a supportive community for recovery.

Materna Medical

Venture Round in 2024
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.

Elektra Health

Seed Round in 2024
Elektra Health is a digital healthcare platform designed to support women navigating perimenopause and menopause, addressing the significant challenges many face during this transition. With 80% of women reporting that menopause disrupts their lives due to symptoms such as anxiety, depression, and joint pain, Elektra aims to fill the gap in care, as 75% of those seeking help do not receive adequate support. The platform focuses on destigmatizing menopause and hormones through comprehensive education, community engagement, and access to medical expertise. Elektra provides telemedicine services from board-certified clinicians, an evidence-based educational program, and a private community, empowering women to take control of their hormonal health and improve their quality of life.

Nest Collaborative

Series A in 2024
Nest Collaborative operates a virtual lactation support platform that connects parents and parents-to-be with board-certified lactation consultants. Accessible year-round, the service focuses on preventive care to enhance breastfeeding success by addressing the unique barriers mothers face, including physiological, emotional, and societal challenges. Through education, guidance, and practical support, Nest Collaborative aims to extend the duration of breastfeeding. The platform provides a comprehensive range of services, including prenatal planning and ongoing support, allowing mothers to easily schedule consultations online without the need for co-pays. By combining evidence-based interventions with accessible care, Nest Collaborative seeks to improve overall maternal and infant health outcomes.

Ciitizen

Seed Round in 2023
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.

Elektra Health

Seed Round in 2023
Elektra Health is a digital healthcare platform designed to support women navigating perimenopause and menopause, addressing the significant challenges many face during this transition. With 80% of women reporting that menopause disrupts their lives due to symptoms such as anxiety, depression, and joint pain, Elektra aims to fill the gap in care, as 75% of those seeking help do not receive adequate support. The platform focuses on destigmatizing menopause and hormones through comprehensive education, community engagement, and access to medical expertise. Elektra provides telemedicine services from board-certified clinicians, an evidence-based educational program, and a private community, empowering women to take control of their hormonal health and improve their quality of life.

Omniox

Series A in 2023
Omniox is a biopharmaceutical company focused on developing innovative treatments for hypoxic diseases, which occur when tissues receive insufficient oxygen. This condition is linked to serious health issues, including various cancers and cardiovascular diseases. The company utilizes a proprietary protein-based platform technology known as H-NOX, which is designed to deliver oxygen and nitric oxide directly to hypoxic tissues. By specifically targeting these areas, Omniox aims to restore normal tissue function, potentially improving patient outcomes and offering new therapeutic options. Through its work, Omniox seeks to advance oxygen-based therapies that address the challenges posed by diseases associated with low oxygen levels.

Pear Bio

Series A in 2023
Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

32Co

Seed Round in 2023
32Co is a medical technology platform focused on enhancing the capabilities of general dentists in delivering clear aligner orthodontics. The company facilitates a collaborative healthcare environment by connecting general dentists with specialist orthodontists for one-on-one mentorship. Through its innovative platform, 32Co employs artificial intelligence to provide educational resources that improve the skills of dental practitioners. This approach enables dentists to offer high-quality orthodontic care and treatments to their patients, thereby enhancing overall patient outcomes in dental healthcare.

Gradient Health

Seed Round in 2023
Gradient Health is a developer of an open research platform focused on providing AI-based medical imaging diagnostics and infrastructure. The platform offers comprehensive access to a clinical sandbox, along with open-source tools and documentation that are readily available to developers. This framework facilitates the translation of research into a secure and interoperable clinical environment, enhancing the capabilities and efficiency of medical imaging diagnostics.

Essenvia

Seed Round in 2023
Essenvia operates an online software platform designed to enhance the regulatory workflow for medical device companies during both pre and post-market phases. The platform features a comprehensive dashboard that facilitates cross-functional collaboration among teams, allowing for improved communication and efficiency. It automates various tasks associated with managing initial and subsequent device modifications, as well as regulatory workflow and administrative processes. By streamlining these activities, Essenvia enables its clients to reduce the time and costs associated with bringing medical devices to market.

TomBot

Seed Round in 2023
Tombot, Inc. is a company that designs and develops robotic companion animals that mimic the appearance and behaviors of real pets, targeting individuals across various age groups, including children, adults, and seniors. Founded in 2017 and based in Valencia, California, Tombot aims to provide companionship and emotional support, particularly for the elderly and individuals with dementia or mild cognitive impairment. The company's robotic pets feature interactive touch, voice recognition systems, and are intended to alleviate feelings of loneliness and anxiety associated with dementia. Tombot's initial product is categorized as a consumer wellness device, with aspirations to achieve FDA classification as a medical device. Through its innovative approach, Tombot seeks to tap into a growing pet industry, addressing the needs of the 200 million individuals who cannot keep live pets due to various constraints. The company has garnered significant interest, with over 7,000 pre-orders from consumers and numerous partnerships with healthcare institutions, and plans to begin beta testing in 2024, followed by customer shipments in 2025.

UptimeHealth

Series A in 2023
UptimeHealth, based in Boston, MA, is a software startup that specializes in equipment management for the healthcare sector. Its platform simplifies the management of medical device service events, purchases, and compliance through automation and predictive analytics. By offering user-friendly software, UptimeHealth enables administrators and operators to efficiently manage compliance tasks and access actionable data, thereby enhancing operational efficiencies. The company also connects users to a vast network of qualified biomedical technicians to support their medical devices. UptimeHealth's solutions aim to reduce costs and improve the quality of medical services by streamlining maintenance processes, automating documentation, and ensuring adherence to industry standards.

Advocatia

Series A in 2022
Advocatia Solutions, Inc. is a provider of benefit advocacy and enrollment software aimed at helping hospitals and employers support uninsured and underinsured patients in accessing available benefits. Founded in 2016 and based in Lake Bluff, Illinois, Advocatia offers a range of tools, including Benefit Screening, Benefit Text, and Benefit Triage, which facilitate the navigation of healthcare options. By partnering with Advocatia, hospitals can reduce bad debt, enhance internal workflows, and establish an audit trail for enrollment processes. The platform streamlines the financial assistance process, enabling healthcare organizations to effectively engage and enroll patients in programs that improve health outcomes and reduce costs, thus promoting better access to care for individuals after hospital discharge.

Skin Analytics

Series A in 2022
Skin Analytics, established in 2012 and headquartered in London, specializes in online healthcare services focused on skin health. The company uses smartphone photography and proprietary algorithms to transform images into valuable data, aiding dermatologists in diagnosis and treatment decisions. By building a digital history of the skin, Skin Analytics empowers individuals and healthcare professionals to monitor, track, and understand skin conditions, ultimately improving skin health. The company's patent-pending technology enables early detection of melanoma and other skin cancers, as well as precancerous lesions, with a focus on delivering a range of consumer and clinical skin health products over the next three years.

Ufonia

Seed Round in 2022
Ufonia is focused on transforming routine patient healthcare interactions by utilizing advanced AI-driven voice technology. The company develops automated phone calls that facilitate clinical follow-up, allowing healthcare organizations to efficiently capture patient-reported outcome measures. Through its conversational voice bot, Ufonia enables healthcare providers to monitor patient health and wellness more effectively, streamlining communication and enhancing the overall patient experience.

Carlsmed

Series B in 2022
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Nest Collaborative

Seed Round in 2022
Nest Collaborative operates a virtual lactation support platform that connects parents and parents-to-be with board-certified lactation consultants. Accessible year-round, the service focuses on preventive care to enhance breastfeeding success by addressing the unique barriers mothers face, including physiological, emotional, and societal challenges. Through education, guidance, and practical support, Nest Collaborative aims to extend the duration of breastfeeding. The platform provides a comprehensive range of services, including prenatal planning and ongoing support, allowing mothers to easily schedule consultations online without the need for co-pays. By combining evidence-based interventions with accessible care, Nest Collaborative seeks to improve overall maternal and infant health outcomes.

Camino Robotics

Seed Round in 2022
Camino Robotics produces and sells senior wellness products with features including an auto break, auto parking, auto lighting, and auto boosting. They sell their products online as well as offer home delivery services.

Gradient Health

Seed Round in 2022
Gradient Health is a developer of an open research platform focused on providing AI-based medical imaging diagnostics and infrastructure. The platform offers comprehensive access to a clinical sandbox, along with open-source tools and documentation that are readily available to developers. This framework facilitates the translation of research into a secure and interoperable clinical environment, enhancing the capabilities and efficiency of medical imaging diagnostics.

Epitel

Series A in 2022
Epitel is a digital health company focused on developing a wearable, wireless EEG monitoring platform aimed at improving seizure detection. The company offers a brain health monitoring device that accurately identifies abnormal brain activities using a proprietary cloud-based wearable sensor system combined with advanced artificial intelligence technologies. This innovative approach provides accessible, affordable, and reliable electrographic seizure detection, allowing physicians, caregivers, and patients with neurological disorders to gain valuable insights into brain health. By enhancing the quality of life and care for individuals affected by these conditions, Epitel strives to make significant contributions to the field of digital health.

Kiddo Health

Series A in 2022
Kiddo Health Inc is a company that offers a connected care platform aimed at enhancing the health management of children, particularly those facing physical and behavioral health challenges. The platform features a smart pediatric band designed for children aged three and above, which monitors vital signs such as perspiration, activity levels, heart rate, and skin temperature. Accompanied by a companion app, this system provides parents with actionable health insights, alerts, and recommendations to ensure they remain informed about their child's health. Additionally, Kiddo Health integrates care features like Telehealth and doctor appointment management, enabling healthcare providers to deliver proactive care while potentially reducing admission rates. By focusing on these aspects, Kiddo Health strives to support the overall well-being of school-aged children and adolescents.

Sonic Incytes Medical

Series A in 2021
Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company aims to enhance routine liver health evaluation through non-invasive methods that provide reliable diagnostic accuracy. Its portable ultrasound devices are designed for point-of-care diagnostics and procedure guidance, enabling healthcare practitioners to improve the standard of care in quantifying conditions such as fatty liver disease. Through its innovative technology, Sonic Incytes seeks to facilitate better management of liver health for patients.

TripleBlind

Series A in 2021
TripleBlind, Inc. is a Kansas City-based company incorporated in 2019 that provides an online platform enabling organizations to collaborate while safeguarding sensitive data and algorithms. The company specializes in privacy-enhancing computation, offering a software-only solution delivered through a simple API. TripleBlind focuses on sectors such as healthcare and financial services, utilizing innovations like federated learning and multi-party computation to enhance the scalability and efficiency of privacy-preserving technology. Its platform allows institutions to share and monetize regulated data without compromising privacy, ensuring compliance with regulations like HIPAA and GDPR. By facilitating collaboration around sensitive data without decryption, TripleBlind enables clients to generate new revenue, derive deeper insights, and improve modeling and analysis. The company is supported by notable investors including Accenture, General Catalyst, and The Mayo Clinic, and it integrates seamlessly with major cloud platforms.

TomBot

Seed Round in 2021
Tombot, Inc. is a company that designs and develops robotic companion animals that mimic the appearance and behaviors of real pets, targeting individuals across various age groups, including children, adults, and seniors. Founded in 2017 and based in Valencia, California, Tombot aims to provide companionship and emotional support, particularly for the elderly and individuals with dementia or mild cognitive impairment. The company's robotic pets feature interactive touch, voice recognition systems, and are intended to alleviate feelings of loneliness and anxiety associated with dementia. Tombot's initial product is categorized as a consumer wellness device, with aspirations to achieve FDA classification as a medical device. Through its innovative approach, Tombot seeks to tap into a growing pet industry, addressing the needs of the 200 million individuals who cannot keep live pets due to various constraints. The company has garnered significant interest, with over 7,000 pre-orders from consumers and numerous partnerships with healthcare institutions, and plans to begin beta testing in 2024, followed by customer shipments in 2025.

Strados Labs

Seed Round in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

Strados Labs

Series A in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.

DeepScribe

Seed Round in 2021
DeepScribe Inc, established in 2017 and headquartered in Berkeley, California, offers an AI-powered medical scribe platform that automates the process of medical documentation for healthcare providers. The technology uses artificial intelligence, machine learning, and natural language processing to capture and transcribe clinical conversations in real time, extracting pertinent medical information and organizing it into cohesive medical notes. This fully automated solution alleviates the burden of documentation from clinicians, allowing them to concentrate on patient care. DeepScribe's user-friendly mobile application and its integrations with various electronic health record (EHR) vendors enhance the efficiency of capturing documentation, ultimately transforming the way healthcare providers deliver services.

Materna Medical

Series A in 2021
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.

Alertive Healthcare

Seed Round in 2021
Alertive Healthcare is a digital healthcare company focused on addressing the hypertension epidemic and managing chronic diseases. The company has developed a remote healthcare management platform that enables healthcare providers to monitor patients' blood pressure between doctor visits. By utilizing data from FDA-approved, Bluetooth-enabled blood pressure devices, Alertive facilitates effective communication among care teams, allowing for timely clinical recommendations. This innovative approach significantly reduces the time required to achieve blood pressure control, cutting it down from the standard 18-24 months to as little as 10 weeks, ultimately helping patients lead healthier lives.

TripleBlind

Seed Round in 2021
TripleBlind, Inc. is a Kansas City-based company incorporated in 2019 that provides an online platform enabling organizations to collaborate while safeguarding sensitive data and algorithms. The company specializes in privacy-enhancing computation, offering a software-only solution delivered through a simple API. TripleBlind focuses on sectors such as healthcare and financial services, utilizing innovations like federated learning and multi-party computation to enhance the scalability and efficiency of privacy-preserving technology. Its platform allows institutions to share and monetize regulated data without compromising privacy, ensuring compliance with regulations like HIPAA and GDPR. By facilitating collaboration around sensitive data without decryption, TripleBlind enables clients to generate new revenue, derive deeper insights, and improve modeling and analysis. The company is supported by notable investors including Accenture, General Catalyst, and The Mayo Clinic, and it integrates seamlessly with major cloud platforms.

Nest Collaborative

Venture Round in 2021
Nest Collaborative operates a virtual lactation support platform that connects parents and parents-to-be with board-certified lactation consultants. Accessible year-round, the service focuses on preventive care to enhance breastfeeding success by addressing the unique barriers mothers face, including physiological, emotional, and societal challenges. Through education, guidance, and practical support, Nest Collaborative aims to extend the duration of breastfeeding. The platform provides a comprehensive range of services, including prenatal planning and ongoing support, allowing mothers to easily schedule consultations online without the need for co-pays. By combining evidence-based interventions with accessible care, Nest Collaborative seeks to improve overall maternal and infant health outcomes.

Functional Fluidics

Seed Round in 2020
Functional Fluidics Inc. is a company that develops biomarkers and surrogate endpoints for evaluating thrombosis and adhesion formation in whole blood, particularly in the context of sickle cell disease. Founded in 2014 and headquartered in Detroit, Michigan, the company specializes in standardizing clinical blood function assays to assess individual patient responses, focusing on red blood cell health. Functional Fluidics offers a range of proprietary assays that include flow adhesion, mechanical fragility, and adhesion characterization. Additionally, the company provides contract research services, which encompass initial consultation, preclinical validation, patient selection, monitoring, and companion diagnostic development. These services are designed to assist pharmaceutical, biotech, and academic research organizations in improving patient care by providing objective data on red blood cell health.

Carlsmed

Series A in 2020
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Arcuity

Seed Round in 2020
Arcuity is a company that specializes in document retrieval and review systems, utilizing artificial intelligence to enhance the efficiency and security of accessing and sharing records. Its platform offers seamless and verified record retrieval along with full-case document conceptual search capabilities, which help reduce duplicate records and associated costs. Arcuity creates complex reports tailored for litigants, claimants, and insurers, thereby minimizing risks by uncovering critical information. The platform accelerates the claim review process and increases the productivity of legal professionals, allowing teams to read, index, and summarize thousands of pages of documents in minutes using proprietary extractive technologies.

Hypercare

Seed Round in 2020
Hypercare operates a healthcare coordination platform designed to enhance clinical communication and collaboration among providers. This platform addresses the growing complexity of patient care, which often requires input from multiple providers across various departments and specialties. Traditional communication methods in hospitals, such as switchboards and pagers, have proven ineffective, resulting in delays in patient care and suboptimal outcomes. Hypercare's solution facilitates secure and efficient communication among healthcare professionals in diverse settings, including hospitals, long-term care facilities, and community care organizations. By enabling providers to connect quickly and effectively, Hypercare aims to minimize interruptions and improve patient-centered care while ensuring the protection of personal health information.

Noteworth

Seed Round in 2020
Noteworth is a healthcare technology company based in Hoboken, New Jersey, established in 2015. It specializes in a patient data capture and delivery platform that connects healthcare organizations with patient-generated health data. The platform integrates seamlessly with over 400 FDA-approved clinical devices and existing electronic medical records, ensuring that clinicians receive actionable, clinically relevant information. Noteworth's solutions aim to enhance patient engagement by facilitating the collection of vital statistics, providing educational resources regarding diagnoses, and enabling communication between patients and healthcare providers through telemedicine or chat. By improving care coordination and delivering a differentiated experience for patients, Noteworth seeks to enhance the quality of care while reducing costly readmissions and overall healthcare utilization.

Carlsmed

Seed Round in 2020
Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

TomBot

Seed Round in 2020
Tombot, Inc. is a company that designs and develops robotic companion animals that mimic the appearance and behaviors of real pets, targeting individuals across various age groups, including children, adults, and seniors. Founded in 2017 and based in Valencia, California, Tombot aims to provide companionship and emotional support, particularly for the elderly and individuals with dementia or mild cognitive impairment. The company's robotic pets feature interactive touch, voice recognition systems, and are intended to alleviate feelings of loneliness and anxiety associated with dementia. Tombot's initial product is categorized as a consumer wellness device, with aspirations to achieve FDA classification as a medical device. Through its innovative approach, Tombot seeks to tap into a growing pet industry, addressing the needs of the 200 million individuals who cannot keep live pets due to various constraints. The company has garnered significant interest, with over 7,000 pre-orders from consumers and numerous partnerships with healthcare institutions, and plans to begin beta testing in 2024, followed by customer shipments in 2025.

Cellsonics

Venture Round in 2020
Cellsonics is a company focused on advancing single-cell sample preparation to enhance precision medicine in disease analysis, treatment, and diagnosis. By developing ultrasonic energy technology, Cellsonics enables the dissociation of single cells from solid tumor samples, yielding heterogeneous viable cells. This innovation supports scientists and clinicians in tailoring cancer treatment strategies to the unique characteristics of individual patients. The company offers products designed for laboratory processing of solid tissue samples, facilitating applications in single-cell analysis, cancer tumor profiling, and primary tissue culture.

Meenta

Seed Round in 2020
Meenta, Inc. operates a cloud-based platform that facilitates the booking and management of samples for gene sequencing, primarily serving research scientists and service providers in the life sciences sector. Founded in 2016 and based in Boston, Massachusetts, Meenta aims to streamline the fragmented life sciences outsourcing market by providing a centralized marketplace for scientific equipment and clinical tests. The platform enables users to efficiently find, book, and send samples to various host sites, thereby enhancing access to laboratory services and fostering collaboration among researchers.

Materna Medical

Seed Round in 2020
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.

MedPilot

Series A in 2020
MedPilot Inc. is a Cleveland-based company founded in 2014 that provides an AI-driven patient relationship management platform. The company focuses on simplifying administrative and billing processes for healthcare providers and patients. MedPilot's platform features a payment system that clearly explains patient obligations and the reasons behind them. Additionally, it includes post-payment surveys that gather meaningful feedback on the patient experience. The platform also supports patients through a network of navigators who offer billing discounts, customizable payment plans, and advocacy services. By streamlining medical payments and addressing payment-related challenges, MedPilot aims to enhance the overall experience for both patients and healthcare providers.

FastDetect

Seed Round in 2020
FastDetect is a company focused on developing diagnostic equipment for rapid testing of COVID-19 and other pathogens. Founded in 2020 and based in Pasadena, California, FastDetect's systems are designed to test multiple individuals simultaneously, delivering results within minutes. The technology employs the reverse transcription polymerase chain reaction technique to accurately identify infections, facilitating efficient and straightforward on-site testing for clients.

Matterworks

Seed Round in 2020
Matterworks is a developer of an artificial intelligence platform focused on advancing the field of metabolomics within the life sciences. The company's technology enhances analytical capabilities, allowing scientific researchers to conduct faster and more comprehensive metabolomic screenings. By facilitating the discovery and engineering processes, Matterworks aims to accelerate scientific progress and support innovation in various biological applications.

Iterative Scopes

Series A in 2019
Iterative Scopes, Inc. is a Boston-based company founded in 2017 that specializes in developing machine learning-powered diagnostic tools aimed at assisting gastroenterologists in the prevention of colon cancer. The company focuses on providing innovative solutions for physicians and the life sciences sector, particularly in the areas of colorectal cancer and inflammatory bowel disease. By leveraging advanced technology, Iterative Scopes aims to enhance diagnostic accuracy and improve patient outcomes in these critical health areas.

MedPilot

Seed Round in 2019
MedPilot Inc. is a Cleveland-based company founded in 2014 that provides an AI-driven patient relationship management platform. The company focuses on simplifying administrative and billing processes for healthcare providers and patients. MedPilot's platform features a payment system that clearly explains patient obligations and the reasons behind them. Additionally, it includes post-payment surveys that gather meaningful feedback on the patient experience. The platform also supports patients through a network of navigators who offer billing discounts, customizable payment plans, and advocacy services. By streamlining medical payments and addressing payment-related challenges, MedPilot aims to enhance the overall experience for both patients and healthcare providers.

DeepScribe

Seed Round in 2019
DeepScribe Inc, established in 2017 and headquartered in Berkeley, California, offers an AI-powered medical scribe platform that automates the process of medical documentation for healthcare providers. The technology uses artificial intelligence, machine learning, and natural language processing to capture and transcribe clinical conversations in real time, extracting pertinent medical information and organizing it into cohesive medical notes. This fully automated solution alleviates the burden of documentation from clinicians, allowing them to concentrate on patient care. DeepScribe's user-friendly mobile application and its integrations with various electronic health record (EHR) vendors enhance the efficiency of capturing documentation, ultimately transforming the way healthcare providers deliver services.

UptimeHealth

Seed Round in 2019
UptimeHealth, based in Boston, MA, is a software startup that specializes in equipment management for the healthcare sector. Its platform simplifies the management of medical device service events, purchases, and compliance through automation and predictive analytics. By offering user-friendly software, UptimeHealth enables administrators and operators to efficiently manage compliance tasks and access actionable data, thereby enhancing operational efficiencies. The company also connects users to a vast network of qualified biomedical technicians to support their medical devices. UptimeHealth's solutions aim to reduce costs and improve the quality of medical services by streamlining maintenance processes, automating documentation, and ensuring adherence to industry standards.

Ready, Set, Food!

Pre Seed Round in 2019
Ready, Set, Food! is a California-based company founded in 2017 that specializes in manufacturing and selling infant food products designed to help reduce the risk of allergies to peanuts, eggs, and milk. The company offers a gentle, daily system that can decrease the likelihood of developing these common allergies by up to 80%. Its products are available for purchase online, making it accessible for parents seeking to introduce allergenic foods into their infants' diets safely.

Luna

Seed Round in 2019
Luna operates a health and wellness center specializing in physical therapies aimed at addressing various conditions such as orthopedic and sports injuries, senior care, post-surgical rehabilitation, and pain management. The company seeks to enhance the effectiveness of physical therapy by providing greater access to care for patients while offering therapists the autonomy and flexibility necessary to manage their careers effectively. Recognizing the challenges faced by both therapists and patients, Luna is committed to creating an environment that fosters independence and motivation, ultimately leading to improved outcomes and greater satisfaction in the therapy process.

Visual Health Solutions

Seed Round in 2019
Visual Health Solutions specializes in creating multimedia content aimed at enhancing patient understanding and engagement with complex medical information. The company develops a range of products, including 3D medical animations, medical device and pharmaceutical animations, medical illustrations, and interactive anatomy models. By employing a collaborative approach that integrates advanced technology and subject-specific expertise, Visual Health Solutions produces educational training programs designed to help audiences navigate medical conditions and treatment plans more effectively. Their impactful visual communication solutions cater to healthcare providers, clinical professionals, patients, and pharmaceutical and medical device companies, ultimately facilitating informed decision-making in healthcare.

Cellsonics

Seed Round in 2019
Cellsonics is a company focused on advancing single-cell sample preparation to enhance precision medicine in disease analysis, treatment, and diagnosis. By developing ultrasonic energy technology, Cellsonics enables the dissociation of single cells from solid tumor samples, yielding heterogeneous viable cells. This innovation supports scientists and clinicians in tailoring cancer treatment strategies to the unique characteristics of individual patients. The company offers products designed for laboratory processing of solid tissue samples, facilitating applications in single-cell analysis, cancer tumor profiling, and primary tissue culture.

xCures

Seed Round in 2019
xCures, Inc. is a company focused on transforming cancer treatment through its innovative AI-based precision oncology platform, established in 2018 and headquartered in Los Altos, California. The platform addresses the limitations of traditional drug-centric approaches by integrating cancer research with patient care. It operates as a perpetual trial, continuously collecting Real World Evidence (RWE) to enhance decision-making in treatment recommendations for advanced cancer patients. By utilizing machine learning, xCures structures insights from tumor boards and matches patients with the most effective treatment options based on their individual cases. This approach not only streamlines the process for healthcare providers but also reduces the time and cost associated with drug development, ultimately aiming to improve patient outcomes and save lives.

Medaptive Health

Seed Round in 2019
Medaptive Health is an open-source solution focused on enhancing health offerings through the use of CareKit, ResearchKit, ResearchStack, and web technologies. The company specializes in patient engagement technology that aims to transform the operation of clinical trials. By automating engagement, Medaptive Health provides personalized support to large populations and offers analytics that deliver insights into individual and group health data. This approach addresses common challenges in clinical research, allowing organizations to save time and resources while improving the efficiency and effectiveness of their clinical trials.

Advekit

Pre Seed Round in 2019
Advekit, LLC operates an online platform designed to facilitate the connection between patients and mental health professionals. Established in 2017 and based in Venice, California, the platform utilizes users' zip codes, preferences, and insurance details to match them with suitable therapists. By streamlining the search process, Advekit enhances access to quality mental health treatment and allows individuals to better leverage their insurance benefits. Additionally, the platform offers a sliding-scale fee structure, accommodating users based on their financial capabilities. This approach empowers patients by simplifying the often complex journey of finding appropriate mental health support tailored to their needs.

Regard

Seed Round in 2019
Regard is a healthcare technology company that offers an intelligent platform aimed at enhancing hospital operations and patient outcomes. Utilizing artificial intelligence, the platform analyzes medical records to extract relevant information, aiding in the diagnosis of key conditions and generating accurate documentation. This approach not only streamlines administrative tasks but also enhances patient safety and physician satisfaction. By reducing coding queries and minimizing the need for extensive administrative support, Regard empowers healthcare providers to focus more on patient care while optimizing financial outcomes for hospitals.

Giblib

Seed Round in 2019
Giblib is a California-based company founded in 2015, headquartered in Los Angeles. It operates an online video community platform that serves as a resource for medical education, specifically targeting surgical procedures across various specialties. The platform allows surgeons to share curated medical lectures and surgical videos, providing valuable insights into surgical techniques and practices. By indexing every surgical procedure, Giblib enables medical students and practitioners to access high-quality educational content from experienced professionals, enhancing their understanding of medicine and surgery.

Evid Science

Seed Round in 2019
Evid Science specializes in developing an advanced platform that leverages artificial intelligence to analyze and synthesize primary medical literature. By ingesting peer-reviewed articles on pharmaceuticals and clinical research, the platform provides life science companies with a comprehensive and up-to-date database of therapy evidence. This AI-driven solution enhances various stages of the evidence synthesis process, including literature search, screening, analysis, and content creation. As a result, Evid Science facilitates data-driven decision-making and supports clinical needs by accelerating access to critical medical evidence in real time.

Luminate Health

Seed Round in 2019
Luminate Health Inc. offers a Software-as-a-Service solution aimed at laboratories and healthcare providers, facilitating patient engagement by enabling individuals to access, manage, and comprehend their laboratory results through digital platforms. Founded in 2012, the company provides HIPAA-compliant tools that enhance communication between physicians and patients regarding lab results, as well as clinically relevant information. The platform aims to improve patient care by empowering patients to take an active role in their health management while delivering added value to laboratories and their physician clients. Luminate Health is headquartered in San Mateo, California, and maintains a strategic alliance with Psyche Systems Corporation.

Third Eye Health

Series A in 2019
Third Eye Health, Inc. is a healthcare company based in Chicago, Illinois, that specializes in telehealth services for post-acute and senior care organizations. Founded in 2014, the company operates an online platform that facilitates the exchange of medical information and real-time telemedicine through wearable technology. Its flagship product, EmergencyAssist, aids emergency medical technicians, visiting nurses, and staff in rehabilitation facilities by enabling detailed triage and the transmission of critical patient data to hospitals and specialists via real-time video and images. Additionally, Third Eye Health focuses on reducing avoidable hospital readmissions by providing immediate care and consultations, thus enhancing the quality of post-acute care.

Savonix

Series A in 2018
Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

SeqOnce Biosciences

Seed Round in 2018
SeqOnce Biosciences is a biotechnology company dedicated to advancing life sciences discoveries to enhance human health by detecting pathogens and disease-related biomarkers. Founded in 2014 as a spinout from USC, the company focuses on a wide range of genomic applications, including real-time PCR and next-generation sequencing, while also exploring innovative technologies to deliver faster and improved results. With a strong emphasis on product development, SeqOnce specializes in genomic sequencing preparation kits that facilitate qualitative multi-plex in-vitro assessments of common sexually transmitted microbiota. These kits utilize nucleic acid amplification techniques, allowing clinical researchers to conduct cost-effective DNA sequencing for sample preparation. Led by a team with expertise in molecular biology, technology development, finance, and operations, SeqOnce is experiencing rapid growth as it continues to introduce new products across genomics, food safety, and pathogen detection sectors.

Rosalind

Seed Round in 2018
The usual process of learning bioinformatics requires the solution of computational problems of varying difficulty that are extracted from real challenges of molecular biology. In an attempt to make the experience of learning bioinformatics as effective and enjoyable as possible, we have founded Rosalind, a programming and testing platform for bioinformatics problems. The Rosalind website checks solutions to these problems automatically and provides students of all abilities with an intellectually stimulating way to learn key bioinformatics concepts and algorithms online at their own pace and independent of students' access to university resources. Rosalind also promises to facilitate improvements in standard undergraduate bioinformatics education by providing a vital teaching aid. Rosalind is inspired by Project Euler, Google Code Jam, and free online courses. The project's name commemorates Rosalind Franklin, whose X-ray crystallography facilitated the discovery of the double helix by Watson and Crick.

Joany

Seed Round in 2018
JOANY Inc., operating as JOANY Health Insurance Services, is an online insurance brokerage based in Los Angeles, California. Established in 2016 and rebranded from Impact Health in 2017, JOANY provides a range of services designed to streamline the process of buying and managing health insurance. The company utilizes machine learning and a comprehensive database to analyze individual consumer needs, helping clients select suitable insurance plans efficiently. In addition to insurance brokerage, JOANY offers services such as doctor matching, billing counsel, and healthcare navigation, positioning itself as a healthcare concierge to simplify the complexities of health insurance throughout the year.

Trusted Health

Seed Round in 2018
Trusted, Inc. operates a digital employment platform specializing in connecting nurses with flexible job opportunities in the healthcare sector. Founded in 2017 and based in San Francisco, the platform serves as an automated online employment agency that simplifies the recruitment process for both candidates and employers. It allows nurses to manage their resumes, credentials, and certifications while providing real-time alerts about new job openings that match their experience and preferences. Trusted's flagship staffing platform, Trusted Works, addresses the critical staffing challenges faced by healthcare facilities by enabling them to build an on-demand nursing workforce. This platform offers a comprehensive solution for managing clinical workforce needs, including sourcing, onboarding, and compliance, while providing predictive insights to adapt to fluctuating demand. Trusted is supported by various venture capital firms and healthcare innovators, enhancing its role as a leader in the labor marketplace for healthcare professionals.

Kiddo Health

Venture Round in 2018
Kiddo Health Inc is a company that offers a connected care platform aimed at enhancing the health management of children, particularly those facing physical and behavioral health challenges. The platform features a smart pediatric band designed for children aged three and above, which monitors vital signs such as perspiration, activity levels, heart rate, and skin temperature. Accompanied by a companion app, this system provides parents with actionable health insights, alerts, and recommendations to ensure they remain informed about their child's health. Additionally, Kiddo Health integrates care features like Telehealth and doctor appointment management, enabling healthcare providers to deliver proactive care while potentially reducing admission rates. By focusing on these aspects, Kiddo Health strives to support the overall well-being of school-aged children and adolescents.

Good Parent

Seed Round in 2018
Good Parent, Inc., is a corporation established in 2010 to provide scientific research, education, and entertainment to parents, children and educators.

Ciitizen

Venture Round in 2018
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.

Nicolette

Pre Seed Round in 2018
Nicolette, Inc. is a California-based company that develops a parent-facing dashboard application aimed at supporting families with babies in the neonatal intensive care unit (NICU). The application features visual, audio, and interactive displays of health data, allowing parents to track their baby's diagnosis, progress, and care plans. It also includes electronic medical record data, curated research, a directory of healthcare team members, and tools for remote communication with physicians. By empowering parents with individualized medical information and educational resources, Nicolette facilitates better collaboration between families and healthcare professionals. The company was founded in 2016 and aims to enhance patient engagement and understanding in challenging healthcare situations.

Precise TeleHealth

Seed Round in 2018
Precise Telehealth specializes in delivering telemedical services to address the healthcare needs of patients with complex medical and behavioral conditions, particularly those in rural and underserved areas. The company's platform enhances healthcare delivery by enabling doctors to provide improved treatment options, ultimately leading to better clinical outcomes. By focusing on chronic care management, Precise Telehealth aims to reduce the costs associated with multiple chronic diseases while ensuring higher quality care through face-to-face telemedicine interactions. Their collaborative services are designed to identify, monitor, and guide patients, filling critical gaps in the existing healthcare system.

Meenta

Seed Round in 2018
Meenta, Inc. operates a cloud-based platform that facilitates the booking and management of samples for gene sequencing, primarily serving research scientists and service providers in the life sciences sector. Founded in 2016 and based in Boston, Massachusetts, Meenta aims to streamline the fragmented life sciences outsourcing market by providing a centralized marketplace for scientific equipment and clinical tests. The platform enables users to efficiently find, book, and send samples to various host sites, thereby enhancing access to laboratory services and fostering collaboration among researchers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.